Arlington Capital Partners Team

Arlington Capital Partners Team Summary

Arlington Capital Partners’ team includes 14 investment professionals, and 4 admin related team members. The average tenure for the Firm’s senior team is 15 years.

Professionals at Arlington Capital Partners have previously worked for 10 other investment firms including Capitol Partners, Court Square Capital Partners, and H.I.G. Private Equity. Arlington Capital Partners alumni have gone on to work at 10 other investors including Rotunda Capital Partners, Washington Equity Partners, and CapitalSpring.

Sign-up to view Arlington Capital Partners’ full profile and discover more large private equity firm investors just like it.

Team Summary

  • Investment 14
  • Administrative 4

Arlington Capital Partners

Arlington Capital Partners

4747 Bethesda Avenue, Suite 500,
Bethesda, Maryland 20814
United States
(202) 337-7500
www.arlingtoncap.com
requestinfo@arlingtoncap.com

All (18) Senior (9) Midlevel (3) Junior (6)
Name Title Email Phone Office
Matthew Altman Managing Partner confidential@email.com CONFIDENTIAL Bethesda

Matt shares overall responsibilities for all management and investment activities of the firm. Matt has primary responsibility for Arlington’s healthcare investments and shares responsibility for the firm’s aerospace and defense investments. Matt has closed leveraged buyouts, recapitalizations and growth equity investments representing approximately $4.0 billion in value during his 26 year career in private equity. Matt’s private equity experience encompasses a wide range of industries including healthcare, aerospace, defense, industrial manufacturing, specialty distribution and media. Prior to joining Arlington in 2001, Matt worked at Stonington Partners, a $1.0 billion private equity fund established in 1994 by the principals of Merrill Lynch Capital Partners. At Stonington, Matt worked on several healthcare transactions including Packard BioScience Corporation and Obagi Medical Products. Both companies ultimately completed initial public offerings before successful sale transactions. Matt’s responsibilities at Stonington included originating and conducting due diligence of investment opportunities, structuring and negotiating transactions, arranging public and private debt financing, designing management incentive plans and participating in portfolio company management and realizations. Matt was also directly involved in the monitoring and realization of Merrill Lynch Capital Partners investments. Matt earned an M.B.A. from the Stanford Graduate School of Business and graduated summa cum laude from Duke University with a B.A. in Economics. He currently serves on the Executive Committee of the Duke Cancer Institute’s Board of Advisors. Matt currently serves on the Board of Directors of AVS Bio, Everest Clinical Research, Grand River Aseptic Manufacturing, Millstone Medical Outsourcing, Riverpoint Medical, and TEAM Technologies, Inc. Matt has previously been a member of the Board of Directors of Advanced Health Media, Avalign Technologies, Cambridge Major Laboratories, Chandler/May, Cherry Creek Radio, Consolidated Precision Products, Endeavor Robotics, Main Line, MB Aerospace, Micron Technologies, Molecular Products, New Vision Group, Ontario Systems, Tex Tech Industries and United Flexible.

Function: Investment

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.